| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2023 | TEVA Teva Pharmaceutical Industries Ltd | Dethlefs Sven | EVP, North America Commercial | Sell | 77,421 | $9.55 | $739,653.01 | -16.6% | -23.6% | +43.3% | |
| Mar 7, 2023 | LNTH Lantheus Holdings, Inc. | Niedzwiecki Daniel54 | See Remarks | Sell | 10,134 | $72.52 | $734,903.79 | -6.3% | +21.0% | -14.4% | |
| Mar 7, 2023 | LNTH Lantheus Holdings, Inc. | Blanchfield Paul54 | Chief Operating Officer | Sell | 8,008 | $72.42 | $579,945.98 | -4.4% | +21.0% | -14.4% | |
| Mar 6, 2023 | JNJ Johnson & Johnson | Swanson James D. | See Remarks | Sell | 1,062 | $154.66 | $164,199.44 | -10.3% | +1.8% | +2.8% | |
| Mar 6, 2023 | PRGO Perrigo Co Plc | Parker Geoffrey M.46 | Director | Buy | 5,000 | $38.05 | $190,270.00 | +46.0% | -10.6% | -26.2% | |
| Mar 6, 2023 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 94,244 | $73.03 | $6,882,425.16 | -4.1% | +20.0% | -11.7% | |
| Mar 6, 2023 | VTRS Viatris Inc | Ni Xiangyang (sean)50 | President, Greater China | Sell | 6,241 | $11.13 | $69,469.98 | -6.6% | -14.1% | +13.1% | |
| Mar 3, 2023 | ELAN Elanco Animal Health Inc | Hoover R David50 | Director | Buy | 10,000 | $11.13 | $111,300.00 | +6.9% | -22.5% | +44.4% | |
| Mar 3, 2023 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 566 | $10.46 | $5,920.36 | -4.8% | -14.1% | +26.6% | |
| Mar 3, 2023 | IRWD Ironwood Pharmaceuticals Inc | McCourt Thomas A66 | Chief Executive Officer | Sell | 33,756 | $11.22 | $378,742.32 | -5.0% | -3.5% | -19.6% | |
| Mar 3, 2023 | HIMS Hims & Hers Health, Inc. | Dudum Andrew48 | Chief Executive Officer | Sell | 1,249 | $11.96 | $14,933.04 | -0.4% | -14.1% | +26.6% | |
| Mar 3, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $245.94 | $3,935,001.06 | -24.5% | -14.2% | -6.7% | |
| Mar 3, 2023 | VRNO Verano Holdings Corp. | Smullen Richard Michael | Director | Sell | 112,595 | $2.95 | $332,063.08 | -2.3% | - | - | |
| Mar 2, 2023 | AMLX Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd93 | 10% Owner | Sell | 50,000 | $33.75 | $1,687,500.00 | -0.7% | -26.6% | -44.4% | |
| Mar 2, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $242.57 | $1,455,417.61 | -3.8% | -14.3% | -5.2% | |
| Mar 2, 2023 | HIMS Hims & Hers Health, Inc. | Maltz Jules A.72 | 10% Owner | Sell | 36,820 | $10.10 | $371,882.00 | -0.2% | -13.6% | +26.8% | |
| Mar 2, 2023 | HIMS Hims & Hers Health, Inc. | Bard Alex | Director | Sell | 2,819,109 | $10.92 | $30,774,995.02 | -13.9% | -13.6% | +26.8% | |
| Mar 1, 2023 | AKBA Akebia Therapeutics, Inc. | Hadas Nicole R.60 | SVP, Chief Legal Officer | Sell | 13,034 | $0.88 | $11,437.34 | -1.5% | +4.8% | +72.7% | |
| Mar 1, 2023 | HIMS Hims & Hers Health, Inc. | Carroll Patrick Harrison52 | Director | Sell | 20,857 | $11.70 | $244,026.90 | -16.9% | -23.0% | +13.1% | |
| Mar 1, 2023 | HIMS Hims & Hers Health, Inc. | Dudum Andrew48 | Chief Executive Officer | Sell | 36,633 | $11.95 | $437,764.35 | -9.5% | -23.0% | +13.1% | |
| Mar 1, 2023 | UTHR United Therapeutics Corp | Sullivan Louis W62 | Director | Sell | 700 | $245.10 | $171,570.00 | -5.4% | -16.2% | -7.9% | |
| Mar 1, 2023 | AKBA Akebia Therapeutics, Inc. | Dahan Michel59 | SVP, Chief Operating Officer | Sell | 20,412 | $0.88 | $17,911.53 | -2.4% | +4.8% | +72.7% | |
| Mar 1, 2023 | AKBA Akebia Therapeutics, Inc. | Butler John P.61 | CEO And President | Sell | 91,868 | $0.88 | $80,614.17 | -1.9% | +4.8% | +72.7% | |
| Mar 1, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $36.70 | $18,349.27 | -0.2% | +21.3% | +27.4% | |
| Mar 1, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 10,974 | $36.33 | $398,685.42 | -9.8% | +21.3% | +27.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.